An alternative consideration in drug testing in elite athletes

New Zealand Medical Journal

Volumn 121, Issue 1278, 2008, Pages 73-77

  Legge, Michael ^a   Fitzgerald, Ruth ^a   Jones, Lynnette ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTIDEPRESSANT AGENT; ANTIEMETIC AGENT; ANTIHISTAMINIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYTOCHROME P450 2C19; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; DRUG METABOLIZING ENZYME; GLUCURONOSYLTRANSFERASE; NEUROLEPTIC AGENT; OPIATE; CYTOCHROME P450;

ARTICLE; ATHLETE; AWARENESS; CONFIDENTIALITY; DIETARY INTAKE; DOPING; DRUG ABUSE; DRUG DETERMINATION; DRUG METABOLISM; DRUG RESPONSE; ENZYME METABOLISM; ETHNIC DIFFERENCE; FOOD DRUG INTERACTION; GENDER BIAS; GENE DUPLICATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; LIVER METABOLISM; MEDICAL ETHICS; PHARMACOGENETICS; PHARMACOGENOMICS; SPORTS MEDICINE; METHODOLOGY; PHYSIOLOGY; SUBSTANCE ABUSE;

CYTOCHROME P-450 ENZYME SYSTEM; DOPING IN SPORTS; HUMANS; PHARMACOGENETICS; SUBSTANCE ABUSE DETECTION;

EID: 49849085571     PISSN: None     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalised patients: A meta-analysis of prospective studies. JAMA. 1998;279:1200-5.
2. Lin JH, Lu AY. Interindividual variability in inhibition and induction of cytochrome P450 enzymes. Annu Rev Pharmacol Toxicol. 2001;41:535-67.
3. Anderson GD. Sex and racial differences in pharmacological response: where is the evidence? Pharmacogenetics, pharmacokinetics, and pharmacodynamics. J Wornens Health. 2005; 14:19-29.
4. Cascorbi I. Pharmacogenetics of cytochrome p4502D6: Genetic background and clinical implication. Eur J Clin Invest. 2003;33:S17-22.
5. Dresser GK, Bailey DG. The effects of fruit juices on drug disposition: a new model for drug interactions. Eur J Clin Invest. 2003;33:S10-6.
6. Juan D, Worwag DM, Scholler DA, et al. Effects of dietary protein on theophylline pharmacokinetics and caffeine and aminopyrine breath test. Clin Pharmacol Ther. 1986;40:187-94.
7. Kappas A, Anderson KE, Conney AH, Alvares AP. Influence of dietary protein and carbohydrate on antipyrine and theophylline metabolism in man. Clin Pharmacol Ther. 1976;20:643-53.
8. Conney AH, Pantuck EJ, Hsiao KC, et al. Enhanced phenacetin metabolism in human subjects fed charcoal-broiled beef. Clirl Pharmacol Ther. 1976;20:633-42.
9. Kall MA, Clausen J. Dietary effect on mixed function P4501A2 activity assayed by estimation of caffeine metabolism in human. Hum Exp Toxicol. 1995;14:801-7.
10. Kappas A, Alvares AP, Anderson KE, Pantuck EJ, et al. Effect of charcoal-broiled beef on antipyrine and theophylline metabolism. Clin Pharmacol-Ther. 1978;23:445-50.
11. Kall MA, Vang O, Clausen J. Effects of dietary broccoli on human in vivo drug metabolising enzymes: Evaluation of caffeine, oestrone, and chlorzoxazone metabolism. Carcinogenesis. 1996;17:793-9.
12. Pantuck EJ, Pantuck CB, Garland WA, et al. Stimulatory effect of brussels sprouts and cabbage on human drug metabolism. Clin Pharmacol Ther. 1979;25:88-95.
13. Anderson GD. Sex differences in drug metabolism: Cytochrome P-450 and uridine diphosphate glucuronosyltransferase. J Gend Specif Med. 2002;5:25-33.fs